Correlation Between Artiva Biotherapeutics, and Paltalk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Artiva Biotherapeutics, and Paltalk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artiva Biotherapeutics, and Paltalk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artiva Biotherapeutics, Common and Paltalk, you can compare the effects of market volatilities on Artiva Biotherapeutics, and Paltalk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artiva Biotherapeutics, with a short position of Paltalk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artiva Biotherapeutics, and Paltalk.

Diversification Opportunities for Artiva Biotherapeutics, and Paltalk

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Artiva and Paltalk is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Artiva Biotherapeutics, Common and Paltalk in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paltalk and Artiva Biotherapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artiva Biotherapeutics, Common are associated (or correlated) with Paltalk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paltalk has no effect on the direction of Artiva Biotherapeutics, i.e., Artiva Biotherapeutics, and Paltalk go up and down completely randomly.

Pair Corralation between Artiva Biotherapeutics, and Paltalk

Given the investment horizon of 90 days Artiva Biotherapeutics, Common is expected to under-perform the Paltalk. In addition to that, Artiva Biotherapeutics, is 1.02 times more volatile than Paltalk. It trades about -0.01 of its total potential returns per unit of risk. Paltalk is currently generating about 0.0 per unit of volatility. If you would invest  183.00  in Paltalk on September 20, 2024 and sell it today you would lose (3.00) from holding Paltalk or give up 1.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Artiva Biotherapeutics, Common  vs.  Paltalk

 Performance 
       Timeline  
Artiva Biotherapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artiva Biotherapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Artiva Biotherapeutics, is not utilizing all of its potentials. The newest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Paltalk 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Paltalk has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Artiva Biotherapeutics, and Paltalk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Artiva Biotherapeutics, and Paltalk

The main advantage of trading using opposite Artiva Biotherapeutics, and Paltalk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artiva Biotherapeutics, position performs unexpectedly, Paltalk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paltalk will offset losses from the drop in Paltalk's long position.
The idea behind Artiva Biotherapeutics, Common and Paltalk pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Directory
Find actively traded commodities issued by global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules